Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nathalie Ahlström appointed MD of Fazer Confectionery

Nathalie Ahlström has been appointed Managing Director of Fazer Confectionery and member of the Fazer Group Management Team. She has extensive international experience from global companies in leading business roles. For the past six years, she has worked for the global packaging company Amcor, and her present position is Head of the High Performance Laminate Business Unit in Europe. She will join Fazer at the latest in November.Nathalie Ahlström has a truly international background having been based in Singapore and Switzerland, as well as having been responsible for business in multiple

Veidekke ASA: MANDATORY NOTIFICATION OF TRADE

On 25 May 2018 Stiftelsen Veidekkeansattes aksjekjøp (the Veidekke Employee Share Trust) purchased 45 000 Veidekke shares at a price of NOK 93.5989 each. The Trust now holds 758 976 shares. The shares will be resold to employees in Veidekke in the share purchase offer for executives in May 2018, see notification of 14 May 2018. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Change in number of shares in Eyeonid Group AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on January 31st 2018.The number of Notes converted on May 25th 2018 was 25. The number of Notes remaining under the first Tranche for future conversions is 45. The number of shares and the number of votes before the conversion was 51 860 436. Through the conversion, the number of shares and the number of votes have increased by 248 015. The total number of shares and the total number of votes after the conversion amount to 52 108 451.For terms and conditions of the Notes,

NOTE’s incentive program 2018

At NOTE's Annual General Meeting 2018, a decision was taken to introduce an incentive program based on warrants directed at group management and other key persons. A total of 380,000 warrants were granted in accordance with the principles decided by the AGM. The warrants have a maturity of just over three years, until May 2021. The options are traded on market terms. The exercise price amounts to SEK 29.00. Each option entitles the holder to subscribe to one share in NOTE. Including the three-year incentive program of 600,0000 warrants that begun last year, upon full exercise up to

Board and management members of Panion Animal Health AB (publ), subscribes for shares in the current emission

Panion Animal Health AB (“Panion”) is currently offering existing shareholders and others the rights to subscribe for shares in the emission running from 16 – 30 May 2018. The Board of Panion has decided the issue with preference for existing shareholders of a total of approximately SEK 9.2 million. http://panion-animalhealth.com/emisson/ Earlier this week, the CEO of Panion, Anja Holm, announced that she will subscribe for 100.000 SEK in the emission. Now the board members in Panion, Lars Friis Mikkelsen and Dede Willis, the Chief Financial Officer Sofia Josephson, and the Business

Camurus announces NDA resubmission of weekly and monthly buprenorphine depots to FDA

Lund, Sweden — 28 May 2018 — Camurus AB (Nasdaq STO, CAMX) announced today that its US partner Braeburn has resubmitted the New Drug Application (NDA) for CAM2038 weekly and monthly buprenorphine depot injections to the US Food and Drug Administration (FDA) in response to a Complete Response Letter (CRL) received in January 2018. CAM2038 is being developed for the treatment of adults with moderate to severe opioid use disorder, representing a huge global healthcare problem and a public health crisis in the US. We are very pleased that the NDA filing for our weekly and monthly

Sivers IMA granted 3 MSEK for development of 5G mm wave RFIC with integrated antenna

Today Sivers IMA (Nasdaq First North: SIVE) announces that they, together with Uppsala University, has been granted a total contribution of 4 MSEK from “Smartare Elektroniksystem Forsknings- och innovationsprojekt 2018”. The project will be led by Sivers IMA and it will be executed together with the Institution for Technical Science at “Ångströmslaboratoriet” at Uppsala University.The objective with this project is to develop a 5G mmWave RFIC including an integrated antenna in the RFIC package. This implementation can be very cost efficient when used in Customer Premises Equipment (CPE)

Changes in Telia Company's Group Executive Management

Telia Company changes the composition of its Group Executive Management. Anders Olsson, Senior Vice President, Chief Operating Officer and Head of Global Services & Operations (GSO) at Telia Company, has been appointed Executive Vice President and CEO of Telia Sweden. Magnus Zetterberg will replace Olsson as COO and Head of GSO. Henriette Wendt, Senior Vice President and Head of Telia Company’s businesses in Lithuania, Estonia and Denmark, will leave her position and will be replaced by Emil Nilsson who is currently Senior Vice President and Head of Region Eurasia.Anders Olsson has an

Building permit approved for 164 rental apartments in Linköping

On 20 April 2018, Bonava announced the divestment of a rental project in Linköping, Södra Ekkällan, to Bantorget Hyresbostäder, a transaction that was conditional upon the approval of a building permit.The divestment included 164 rental apartments across four buildings with a sales price of approximately SEK 311 million.   Bonava can now announce that the building permit has gained legal force. The project is expected to be recognised in profit from the first quarter of 2020.  For more information, please contact: Ann-Sofi Danielsson, CFO and Head of Investor Relationsann-sofi.

Galaxy Derivatives Company deploys Itiviti’s solution for options market making in China

Hong Kong, May 28, 2018 – Itiviti and ULLINK, the recently merged market-leading global provider of multi-asset trading technology and financial infrastructure, today announced that Galaxy Derivatives Company (GDC) has implemented Itiviti’s trading solution for options market making on Zhengzhou Commodity Exchange (ZCE) and Dalian Commodity Exchange (DCE).Since 2015, Galaxy Futures Co. Ltd. and Itiviti have co-operated to provide high-speed connectivity to Chinese Exchanges, facilitating trading for their mutual clients via Galaxy Futures’ memberships. Acknowledging the scale Itiviti’s

Stora Enso enters into strategic partnership with Swedish University of Agricultural Sciences

STORA ENSO OYJ PRESS RELEASE 28 May 2018 at 9.00 EESTStora Enso has signed a strategic partnership agreement with the Swedish University of Agricultural Sciences (SLU). Through the agreement Stora Enso and SLU intend to establish a long-term collaboration in research and development, education, competence building, and innovation within the fields of forestry and bio-based materials.The main objective of the collaboration is to jointly drive research projects to develop new knowledge within sustainable forestry and wooden biomaterials. Special focus areas include bio-based materials,

NCC dedicates week to health and safety

Safety drills, lectures and NCC’s safety competition to promote innovative solutions for better health and safety at NCC. These are some of the events planned for NCC’s Health and Safety Week, which starts today and is in its third consecutive year.“Health and safety are at the top of our agenda at NCC as we strive to realize our vision of zero work-related accidents. To accomplish this, our vision needs to be firmly rooted at the very top of the company and all the way out to our production sites. It boils down to our leaders being role models and to all of us at NCC creating a

Read original

ContextVision to introduce upcoming digital pathology product - exhibiting at ECDP 2018 in Helsinki

STOCKHOLM - May 28, 2018, - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, is making their first appearance in the field of digital pathology at ECDP/NDP, the 14th European Congress on Digital Pathology and the 5th Nordic Symposium on Digital Pathology, May 29 to June 1. Here, they will be introducing their upcoming product INIFY(TM) Prostate, a new decision support tool based on artificial intelligence and deep learning. INIFY(TM) Prostate is a sophisticated decision support tool with the potential to facilitate and

Redeye: ÅAC Microtec - Positive EBITDA in Q4

This is an updated republication of the research report dated May 8, 2018. It includes our reflexions on the Q1-report and most recent news: A couple of orders from clients who are aiming for big constellations and ÅACs' recent announcement that they expect positive EBITDA in Q4 this year. We have made some minor positive adjustments in our forecasts and valuation. Read more and download the latest research update: https://goo.gl/avJRCm Become a member at Redeye to access the latest research on Life Science and Tech companies. This is a press release from Redeye - Research Powered

Orkla ASA: Trade subject to notification - treasury shares

Orkla ASA has on 25 May 2018 bought 650,000 Orkla shares through broker at an average price of NOK 74.1696 per share. Orkla's total holding of treasury shares after this transaction is 8.941.933 shares. Orkla ASAOslo, 28 May 2018Ref.:IR & Communications ManagerElise HeidenreichTel.: +47 951 41 147 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Share buy-backs in Telia Company during week 21 2018

During the period 21 May, 2018 – 25 May, 2018, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 4 920 000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on 20 April 2018. The share buy-back programme, which runs between 23 April, 2018, and 22 March, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (”MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”).During the period 21 May, 2018 – 25

SEB Investment Outlook: Late-cyclical phase is still sustainable

In line with our expectations, financial markets have been turbulent so far during 2018. The question is whether this is a first step towards a successively more defensive attitude, or much-needed profit-taking during a continued positive trend. Late-cyclical drivers such as strong labour markets and rising capital spending suggest continued healthy growth both this year and next. Political events will cause concerns but probably not hamper growth. In our view, the fundamental outlook remains bright. So far during 2018, we have been moderately overweight in risk assets, such as equities

Höegh LNG : Webcast/Q&A session details for the first quarter of 2018 financial results

Hamilton, Bermuda, 28 May 2018 - Höegh LNG Holdings Ltd. ("Höegh LNG") will release its financial results for the quarter ended 31 March 2018 on Thursday 31 May 2018 at 07:00 am CEST. In connection with this, Höegh LNG will hold a webcast at 09:00 am CEST which will immediately be followed by a Q&A session.The dial-in numbers for the telephone conference are as follows: Norway: +47 2100 2610United Kingdom: +44 (0)330 336 9105United States: +1 323-794-2093Participant passcode: 4502606 The webcast is accessible via a link on Höegh LNG's website or at http://webtv.hegnar.no/

CEO CHANGE AT IMPACT COATINGS

With the goal of becoming financially self-sufficient, the board of directors of Nasdaq First North-listed Impact Coatings has decided to replace CEO Henrik Ljungcrantz. Interim CEO is Torbjörn Sandberg, whose qualifications include being CEO of publicly listed and privately-owned technology companies. “The board of directors thanks Henrik Ljungcrantz for his unique and lasting contributions to Impact Coatings,” said Chairman of the Board Mark Shay. “But new leadership is needed to build a scalable organization that can exploit the company’s opportunities, achieve financial self-sufficiency,

Beactica signs three-year extension agreement with Sanofi

Beactica, the Swedish drug discovery company with world-leading expertise in molecular interactions, today announced that it has signed a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms under which Beactica and Sanofi collaborate on the characterization of interactions between novel therapeutics and their target proteins. As part of the collaboration, Beactica scientists have supported Sanofi with analysis of the interaction kinetics between insulin analogues and their two binding sites on the full-length insulin receptor. Results

Ahlsell issues bond loan totalling MSEK 750

Ahlsell AB (publ) has today finalised a first issue of an unsecured bond with a total amount of MSEK 750 and a tenor of four years. This within the framework in the recently established MTN Programme. The bond loan carries a floating interest rate of three months STIBOR +2.00%. The interest for the issue was very high and the transaction was oversubscribed. The proceeds will be used to refinance parts of existing debt and for general business purposes. Ahlsell will apply for the new bond to be listed on Nasdaq Stockholm's Corporate Bond List. DNB and SEB have been financial

Nordic Nanovector updates on Clinical Trial Applications for Archer-1 and PARADIGME Trials in Norway

Oslo, Norway, 25 May 2018 Nordic Nanovector ASA (OSE: NANO) has received feedback from the Regional Committees for Medical and Health Research Ethics (REK) in Norway with regard to the Clinical Trial Application (CTA) for the Archer-1 Phase 1b trial with Betalutin® (177Lu-satetraxetan-lilotomab) in combination with rituximab in second-line follicular lymphoma patients. Feedback from REK has been received following a review of the CTA for Archer-1, which took place on 26 April. The company and the lead investigator for the trial, Dr Arne Kolstad, senior consultant in medical oncology

CORRECTION: THE MARKETING GROUP PLC, Notice of Annual General Meeting, 8 June 2018

Notice of the Annual General Meeting of the Company to be held at the office of Lewis Silkin LLP, at 5 Chancery Lane, Clifford’s Inn, London EC4A 1BL on 8 June 2018 commencing at 12.00 pm UK time is set out at the end of this document. Whether or not you propose to attend the Annual General Meeting, please complete and submit a proxy form in accordance with the instructions printed on the enclosed form. The proxy form must be received by no later than 12.00 pm UK time on 6 June 2018.   17 May 2018 Dear Shareholder. 2018 Annual General Meeting I am pleased to enclose the

There are no items matching the current filter
There are no more items matching the current filter
Back to top